The Letter probes whether MindMed's internal controls are adequate to ensure that MindMed accurately reports financial results considering Ernst & Young's disclosure that the Company had a material weakness in its internal controls under Sarbanes-Oxley in FY 2021. Subsequently, MindMed terminated Ernst & Young after reporting the material weakness. The Letter also notes that, concurrent to the accounting errors, MindMed's management received an employment package where they would receive significant benefits in the event of resignation or termination (the "Golden Parachute"). "It is abhorrent that the Board believes that it is more important to ensure management has golden parachutes rather than performing the most basic oversight on MindMed's filings," said FCM's Chief Executive Manager Jake Freeman.